Serial Number | 78355965 |
Word Mark | EE |
Filing Date | Thursday, January 22, 2004 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, August 10, 2009 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, April 18, 2006 |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Description of Mark | The mark consists of stylized letter "E" connected to another transposed stylized letter "E" in a top to bottom alignment. |
Goods and Services | Medical diagnostic and therapeutic preparations for clinical use, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold as a kit, namely inhalers; medical preparations namely nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 2, 2004 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | EPIGENESIS PHARMACEUTICALS LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | CRANBURY, NJ 08512 |
Party Name | EPIGENESIS PHARMACEUTICALS LLC |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | CRANBURY, NJ 08512 |
Party Name | EPIGENESIS Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cranbury, NJ 08512 |
Event Date | Event Description |
Monday, August 10, 2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Monday, August 10, 2009 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, January 6, 2009 | EXTENSION 5 GRANTED |
Tuesday, January 6, 2009 | EXTENSION 5 FILED |
Tuesday, January 6, 2009 | TEAS EXTENSION RECEIVED |
Tuesday, July 1, 2008 | EXTENSION 4 GRANTED |
Tuesday, July 1, 2008 | EXTENSION 4 FILED |
Tuesday, July 1, 2008 | TEAS EXTENSION RECEIVED |
Monday, January 7, 2008 | EXTENSION 3 GRANTED |
Monday, January 7, 2008 | EXTENSION 3 FILED |
Monday, January 7, 2008 | TEAS EXTENSION RECEIVED |
Sunday, September 9, 2007 | EXTENSION 2 GRANTED |
Tuesday, July 3, 2007 | EXTENSION 2 FILED |
Tuesday, July 3, 2007 | TEAS EXTENSION RECEIVED |
Tuesday, March 13, 2007 | EXTENSION 1 GRANTED |
Friday, January 5, 2007 | EXTENSION 1 FILED |
Friday, January 5, 2007 | TEAS EXTENSION RECEIVED |
Tuesday, July 11, 2006 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 18, 2006 | PUBLISHED FOR OPPOSITION |
Wednesday, March 29, 2006 | NOTICE OF PUBLICATION |
Friday, March 3, 2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, February 24, 2006 | ASSIGNED TO LIE |
Wednesday, February 22, 2006 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, February 22, 2006 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 14, 2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 14, 2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, September 6, 2005 | NON-FINAL ACTION E-MAILED |
Tuesday, September 6, 2005 | NON-FINAL ACTION WRITTEN |
Friday, September 2, 2005 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Monday, August 15, 2005 | WITHDRAWN BEFORE PUBLICATION |
Tuesday, July 26, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, July 22, 2005 | ASSIGNED TO LIE |
Thursday, July 21, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, July 20, 2005 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, July 11, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 11, 2005 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, March 9, 2005 | NON-FINAL ACTION E-MAILED |
Wednesday, March 9, 2005 | NON-FINAL ACTION WRITTEN |
Tuesday, March 1, 2005 | AMENDMENT FROM APPLICANT ENTERED |
Monday, January 31, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 31, 2005 | PAPER RECEIVED |
Tuesday, October 5, 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Saturday, August 21, 2004 | NON-FINAL ACTION E-MAILED |
Thursday, August 12, 2004 | ASSIGNED TO EXAMINER |
Tuesday, July 20, 2004 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Friday, July 16, 2004 | PAPER RECEIVED |
Monday, February 2, 2004 | NEW APPLICATION ENTERED IN TRAM |